CONTACT US

IRBM’s Promidis Announces Major HBV Agreement with Lombardy

MILAN, June 20, 2017 – IRBM announced today that a scientific consortium led by its subsidiary Promidis received a 5.6 million euro grant from the Italian region of Lombardy to discover and develop innovative cures for chronic hepatitis B, a disease which still affects a significant portion of the world population, despite the availability of a vaccine. Chronic hepatitis B is a significant burden on national health systems, and can lead to severe complications, especially in children. Continue Reading

Comments (0) All News, Press Release

Read more

IRBM Science Park S.p.A. Awarded BRAVEinMS Grant

ROME, September 15, 2016 – IRBM Science Park S.p.A. is among eight research institutions, both private and public, which have been awarded the 12.6 million euro grant, BRAVEinMS, issued by the Progressive MS Alliance. Continue Reading

Comments (0) All News, Press Release

Read more

CNCCS Joins PRONAT Project

VITERBO (VT), June 30, 2016 – IRBM’s CNCCS consortium joined the Università della Tuscia, the Italian National Research Council (CNR), and the Italian Department of Instruction, University and Research (MIUR) in announcing the joint PRONAT project, aimed at identifying bioactive agents of animal or plant origin. Continue Reading

Comments (0) All News, Press Release

Read more

IRBM Presents Final Results at AICI Meeting

ROME, June 24, 2015 – The final results of the Italian- and European-funded AICI project (Approcci Innovativi per il Controllo delle Infezioni, Innovative Approaches for Infection Control), activated in 2013 and carried out by a network of biotech companies such as IRBM Science Park S.p.A., Angelini, Ylichron and IBN Savio, were presented at a final workshop at the Angelini Research Center in St. Palomba (RM). Continue Reading

Comments (0) All News, Press Release

Read more